|
|
||||||||
INVITED REVIEW
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California
Prostate-specific membrane antigen (PSMA) is a metallopeptidase expressed predominantly in prostate cancer (PCa) cells. PSMA is considered a biomarker for PCa and is under intense investigation for use as an imaging and therapeutic target. Although the clinical utility of PSMA in the detection and treatment of PCa is evident and is being pursued, very little is known about its basic biological function in PCa cells. The purpose of this review is to highlight the possibility that PSMA might be a multifunctional protein. We suggest that PSMA may function as a receptor internalizing a putative ligand, an enzyme playing a role in nutrient uptake, and a peptidase involved in signal transduction in prostate epithelial cells. Insights into the possible functions of PSMA should improve the diagnostic and therapeutic values of this clinically important molecule.
prostate cancer; receptor; peptidase; endocytosis
This article has been cited by other articles:
![]() |
S. A. Rajasekaran, J. J. Christiansen, I. Schmid, E. Oshima, K. Sakamoto, J. Weinstein, N. P. Rao, and A. K. Rajasekaran Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability Mol. Cancer Ther., July 1, 2008; 7(7): 2142 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Chu, J. W. Marks III, L. A. Lavery, S. Faulkner, M. G. Rosenblum, A. D. Ellington, and M. Levy Aptamer:Toxin Conjugates that Specifically Target Prostate Tumor Cells. Cancer Res., June 15, 2006; 66(12): 5989 - 5992. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |